All articles by Staff Writer
Beckman coulter Announces FDA clearance of DxC 500i clinical Analyzer, an integrated Clinical Chemistry and Immunoassay System
The new DxC 500i Analyzer Offers Flexibility and Scalability with Broad Chemistry and Immunoassay Assay Menu
Taking the pressure off
Recognising its clinical and economic benefi ts, more countries are making negative pressure wound therapy more accessible in community settings, but challenges remain. Jim Banks speaks to Viviana Gonçalves, a complex wound care specialist at Centro Hospitalar e Universitário de São João, Alexandre Rodrigues of the Universidade de Aveiro, and Maria Guedes, a specialist in tissue viability at the Duorum Saúde Clinic, about the opportunities and obstacles that lie ahead in bringing NPWT to more patients.
Breathe easy
Ventilator-associated pneumonia (VAP) is one of the common and deadly respiratory tract infections. Affecting patients who are already critically ill in hospital settings, it can worsen already grave outcomes. So how can hospitals work to prevent and treat this infection? Abi Millar speaks to Freya Harrison, a microbiologist working in the School of Life Sciences at the University of Warwick, to find out why VAP is so hard to treat and how patients might benefi t from the latest research advances.
Fighting malaria with AI
Malaria diagnostics is a multi-pronged field, with no one method providing a silver bullet, and researchers always trying to add more tools to their arsenal. Elly Earls sat down with Roxanne Rees-Channer, a malaria researcher at the Hospital for Tropical Diseases at UCLH, to find out how one of the newest prongs – AI – could act as a valuable support tool for overwhelmed remote clinics.
A new era of early detection
There is no single test used to diagnose Alzheimer’s – it is usually a result of several tests and assessments. While for some, a diagnosis can be simple and quick, for others it can take far longer. However, when it comes to Alzheimer’s disease, early diagnosis is vital for patients to receive the care and treatment they need. Phoebe Galbraith speaks to Niklas Mattsson- Carlgren, MD, PhD, associate professor at the Clinical Memory Unit at Lund University, and neurologist at the Memory Clinic, Skåne University Hospital; and Suzanne E. Schindler, MD, PhD, associate professor of neurology at Washington University School of Medicine and Fluid Biomarker Core Leader, as they discuss new and emerging diagnostics tools for Alzheimer’s disease and the potential it has for early diagnosis and treatment.
Q-linea shares progress on roll-out in the Middle East
Q-linea AB (publ) (OMX: QLINEA) today shared updates on the progress of the introduction of ASTar® System in the GCC region.
QIAGEN receives positive court decision reaffirming an important QuantiFERON-TB patent
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the German Federal Patent Court (Bundespatentgericht) has ruled in its favor in a patent dispute against SD Biosensor, reaffirming the validity of an important patent protecting key innovations in its QuantiFERON technology.
Informa Markets unveils WHX Labs Dubai, marking a new era for laboratory innovation
On the second day of Medlab Middle East today, Informa Markets officially announced the exhibition’s rebranding to WHX Labs Dubai, underscoring a transformative vision for connecting people, businesses, governments and innovators across borders.
Beckman Coulter Receives FDA Breakthrough Device Designation for Alzheimer’s Disease Blood Test
Beckman Coulter Diagnostics, a global leader in clinical diagnostics, today announced the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to Beckman Coulter’s Access p‑Tau217/β-Amyloid 1-42 plasma ratio. This blood test is designed to aid healthcare providers identify patients with amyloid pathology associated with Alzheimer’s disease.
Cormica expands US presence with acquisition of Focus Laboratories
Cormica continues expansion with acquisition of microbiological testing firm, Focus Laboratories, following strategic German acquisition